Publications

研究成果

研究業績目録

(原著論文、総説、著書)

<2019/R1>

1. Ueda A, Oikawa K, Fujita K, Ishikawa A, Sato E, Ishikawa T, Kuroda M, Kanekura K. Therapeutic potential of PLK1 inhibition in triple-negative breast cancer. Lab Invest. 2019 Apr 17. doi: 10.1038/s41374-019-0247-4. [Epub ahead of print]

<2018/H30>

1.Kurata A, Saito A, Hashimoto H, Fujita K, Ohno SI, Kamma H, Nagao T, Kobayashi S, Yamashina A, Kuroda M.

Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: it may be better to distinguish them in the same age.

Mod Rheumatol. 2019 Jan 21:1-10. doi: 10.1080/14397595.2019.1570999. [Epub ahead of print]

2. Iida M, Hazama S, Tsunedomi R, Tanaka H, Takenouchi H, Kanekiyo S, Tokumitsu Y, Tomochika S, Tokuhisa Y, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yamamoto S, Yoshino S, Fujita K, Kuroda M, Nagano H.

Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.

Oncol Rep. 2018 Sep;40(3):1621-1631. doi: 10.3892/or.2018.6575. Epub 2018 Jul 13.

3. Higuchi H, Yamakawa N, Imadome KI, Yahata T, Kotaki R, Ogata J, Kakizaki M, Fujita K, Lu J, Yokoyama K, Okuyama K, Sato A, Takamatsu M, Kurosaki N, Alba SM, Azhim A, Horie R, Watanabe T, Kitamura T, Ando K, Kashiwagi T, Matsui T, Okamoto A, Handa H, Kuroda M, Nakamura N, Kotani A.

Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.

Blood. 2018 Jun 7;131(23):2552-2567. doi: 10.1182/blood-2017-07-794529. Epub 2018 Apr 22.

4. Umehara R, Kurata A, Takanashi M, Hashimoto H, Fujita K, Nagao T, Kuroda M. 

Fascin as a useful marker for identifying neural components in immature teratomas of human ovary and those derived from murine embryonic stem cells.

Int J Gynecol Pathol. 2018 May 30. doi: 10.1097/PGP.0000000000000528. [Epub ahead of print]

5. Ikehata N, Takanashi M, Satomi T, Watanabe M, Hasegawa O, Kono M, Enomoto A, Chikazu D, Kuroda M.

Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2227-2234. doi: 10.1016/j.bbrc.2017.12.098.

 

6.Kurata A, Yamada M, Ohno S, Inoue S, Hashimoto H, Fujita K, Takanashi M, Kuroda M. 

Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.

Oncol Rep. 2018 Jan;39(1):91-100. doi: 10.3892/or.2017.6093.

 

<2017/H29>

1. Hashimoto H, Kurata A, Kikuchi H, Masuda Y, Fujita K, Okuyama R, Inoue S, Horiuchi H, Kuroda M. 

L-type amino acid transporter 1 expression in esophageal carcinogenesis according to WHO and Japanese classifications of intraepithelial neoplasia. Pathol Int. 2017 May;67(5):247-255. doi: 10.1111/pin.12528. Epub 2017 Mar 29.PMID:28370814.

2. Hongo-Kohama M, Kurata A, Hashimoto H, Fujita K, Horiuchi H, Nagao T, Kuroda M.

Vascular Smooth Muscle Cell Maturation Stage and Ki-67 Index are Diagnostic Biomarkers for Pathologic Grade of Ovarian Teratoma. Int J Gynecol Pathol. 2017 Mar 17. doi: 10.1097/PGP.0000000000000373. [Epub ahead of print] PMID:28319573

 

3. ikawa K, Mizusaki A, Takanashi M, Ozaki T, Sato F, Kuroda M, Muragaki Y. 

PRG4 expression in myxoid liposarcoma maintains tumor cell growth through suppression of an antitumor cytokine IL-24.Biochem Biophys Res Commun. 2017 Mar 25;485(1):209-214. doi: 10.1016/j.bbrc.2017.02.055. Epub 2017 Feb 10.

4. Oikawa K, Saito A, Kiyuna T, Graf HP, Cosatto E, Kuroda M. 

Pathological Diagnosis of Gastric Cancers with a Novel Computerized Analysis System. J Pathol Inform. 2017 Feb 28;8:5. doi: 10.4103/2153-3539.201114. eCollection 2017.

5. Makino Y, Yoon JH, Bae E, Kato M, Miyazawa K, Ohira T, Ikeda N, Kuroda M, Mamura M. 

Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma. Biochem Biophys Res Commun. 2017 Mar 4;484(2):269-277. doi: 10.1016/j.bbrc.2017.01.093. Epub 2017 Jan 20. PMID:28115165.

6. Yamada Y, Takanashi M, Sudo K, Ueda S, Ohno S, Kuroda M. 

Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis. PLoS One. 2017 Feb 24;12(2):e0171957. doi: 10.1371/journal.pone.0171957. eCollection 2017. PMID:28234907.

7. Kurata A, Nishida J, Koyama T, Miki T, Hashimoto H, Yamamoto K, Kuroda M.

Case report of 2 sudden deaths after surgery for bone fracture:

Usefulness of immunohistochemical analysis of coronary artery for identifying acute myocardial infarction.

Medicine (Baltimore). 2017 May;96(21):e7006. doi: 10.1097/MD.0000000000007006.PMID: 28538416.

 

<2016/H28>

1. Nakaya M, Watari K, Tajima M, Nakaya T, Matsuda S, Ohara H, Nishihara H, Yamaguchi H, Hashimoto A, Nishida M, Nagasaka A, Horii Y, Ono H, Iribe G, Inoue R, Tsuda M, Inoue K, Tanaka A, Kuroda M, Nagata S, Kurose H. 

Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction. 

J Clin Invest. 2017 Jan 3;127(1):383-401. doi: 10.1172/JCI83822. Epub 2016 Dec 5.

2. Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y. 

MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice. 

Mol Ther. 2016 Oct;24(10):1848-1859. doi: 10.1038/mt.2016.127.

3. Hashimoto H, Hara K, Matsumoto J, Nashiro T, Nagano M, Kusakabe M, Kurata A, Kuroda M, Suzuki Y, Horiuchi H. 

Necrotizing arteritis occurring in an intralobar pulmonary sequestration of a patient without systemic vasculitis syndrome. 

Cardiovasc Pathol. 2016 May-Jun;25(3):200-2. doi: 10.1016/j.carpath.2016.01.005. Epub 2016 Jan 22. PMID:26874730.

4. Ohno S, Itano K, Harada Y, Asada K, Oikawa K, Kashiwazako M, Okuyama H, Kumagai K, Takanashi M, Sudo K, Ikeda N, Kuroda M. 

Development of Novel Small Hairpin RNAs That do not Require Processing by Dicer or AGO2. 

Mol Ther. 2016 Aug;24(7):1278-89. doi: 10.1038/mt.2016.81. Epub 2016 Apr 25.

5. Mori A, Nishi H, Sasaki T, Nagamitsu Y, Kawaguchi R, Okamoto A, Kuroda M, Keiichi Isaka.(Mori A, Nishi H, Sasaki T, Nagamitsu Y, Kawaguchi R, Okamoto A, Kuroda M, Isaka K.) 

HLA-G expression is regulated by miR-365 in trophoblasts under hypoxic conditions. 

Placenta. 2016 Sep;45:37-41. doi: 10.1016/j.placenta.2016.07.004. Epub 2016 Jul 21.

6. Fujinaga H, Fujinaga H, Watanabe N, Kato T, Tamano M, Terao M, Takada S, Ito Y, Umezawa A, Kuroda M. 

Cord blood-derived endothelial colony-forming cell function is disrupted in congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1143-54. doi: 10.1152/ajplung.00357.2015. Epub 2016 Apr 29.

7Hashimoto H, Kurata A, Fujiwara M, Hara K, Matsumoto J, Kusakabe M, Tachibana K, Nashiro T, Terado Y, Akahane M, Usui K, Suzuki Y, Kondo H, Kamma H, Kuroda M, Horiuchi H. 

Solitary Pulmonary Capillary Hemangioma of Adult Cases: Clinicopathologic Characteristics as an Unrecognized Entity. 

Am J Surg Pathol. 2016 Oct;40(10):1380-9. doi: 10.1097/PAS.0000000000000708.

8. Taketani Y, Usui T, Toyono T, Shima N, Yokoo S, Kimakura M, Yamagami S, Ohno S, Onodera R, Tahara K, Takeuchi H, Kuroda M. 

Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization. 

Mol Ther Nucleic Acids. 2016 Mar 8;5:e292. doi: 10.1038/mtna.2016.1.

9. Kanekura K, Nishi H, Isaka K, Kuroda M. 

MicroRNA and gynecologic cancers. 

J Obstet Gynaecol Res. 2016 Apr 20. doi: 10.1111/jog.12995.

10. Kanekura K, Yagi T, Cammack AJ, Mahadevan J, Kuroda M, Harms MB, Miller TM, Urano F. 

Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. 

Hum Mol Genet. 2016 Feb 29. pii: ddw052. 

11. Ohno S, Drummen GP, Kuroda M.

Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems. 

Int. J. Mol. Sci. 2016 Feb 6;17(2). pii: E172. doi: 10.3390/ijms17020172.

12Yamada M, Saito A, Yamamoto Y3 Cosatto E, Kurata A, Nagao T, Tateishi A, Kuroda M.

Quantitative nucleic features are effective for discrimination of intraductal proliferative lesions of the breast. 

J Pathol Inform 2016, 7:1 (29 January 2016) DOI: 10.4103/2153-3539.175380

 

<2015/H27>

1.  Hashimoto H, Kurata A, Mizuno H, Nashiro T, Hangaishi A, Kuroda M, Usuki K, Horiuchi H.

Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):15391-5. eCollection 2015. PMID:26823900.

2. Hashimoto H, Kurata A, Nashiro T, Inoue S, Ushijima T, Fujita K, Kimura T, Kawai K, Horiuchi H, Kuroda M.

Smooth muscle immaturity in the carotid arterial neointima as a prognostic marker for systemic atherogenic cardiovascular events in the Asian male. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14630-9. eCollection 2015. PMID:26823786.

3. Hashimoto H, Kurata A, Kuroda M, Kishimoto M.

Improvement of IgG4-related Disease with a Supplemental Steroid.

Intern Med. 2015;54(22):2949-50. doi: 10.2169/internalmedicine.54.4561.

4. Takanashi M, Sudo K, Ueda S, Ohno S, Yamada Y, Osakabe Y, Goto H, Matsunaga Y, Ishikawa A, Usui Y, Kuroda M.

Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model. Mol Ther Nucleic Acids. 2015 Oct 20;4:e258. doi: 10.1038/mtna.2015.34.

5.  Hashimoto H, Kurata A, Nashiro T, Kuroda M, Horiuchi H.

Does perineural invasion of the myenteric plexus have a key role in annular rectal invasion and digestive system symptoms of prostate carcinoma patients?

Med Hypotheses. 2015 Dec;85(6):854-7. doi: 10.1016/j.mehy.2015.09.024. Epub 2015 Sep 28.

6. Yoon JH, Sudo K, Kuroda M, Taniguchi T, Kato M, Lee IK, Han JS, Nakae S, Imamura T, Kim J, Ju JH, Kim DK, Matsuzaki K, Weinstein M, Nakao A, Matsumoto I, Sumida T, Mamura M.

Phosphorylation status determines the opposing functions of Smad2 and Smad3 as STAT3 cofactors in TH17 differentiation.

Nature communications. 2015 July 21 ;6:7600. doi: 10.1038/ncomms8600.

7. Nakayama Y, Yamada M, Kurata A, Kiseki H, Kuroda M.

Evaluation of the Human Papillomavirus mRNA Test for the detection of cervical lesions in Japan.

Eur J Gynaec  Oncol (European journal of gynaecological oncology). 36(2):192-6. 2015.

8. Hashimoto H, Kurata A, Fujita K, Shimada H, Nagai T, Horiguchi H, Kuroda M.

Ovarian small cell carcinoma of pulmonary type appearing in ante mortem ascites: An aoutopsy case and review of the literature.

Human Pathology. EHPC-00037; No of Pages 6.  2015 Feb. doi: 10.1016/j.ehpc.2015.02.003.

9. Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T.

Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.

Gene Ther. 2015 Feb;22(2):127-37. doi: 10.1038/gt.2014.112. Epub 2014 Dec 11.

10. Toyono T, Usui T, Yokoo S, Taketani Y, Nakagawa S, Kuroda M, Yamagami S, Amano S.

Angiopoietin-like 7 is an anti-angiogenic protein required to prevent vascularization of the cornea.

PLoS One. 2015 Jan 26;10(1):e0116838. doi: 10.1371/journal.pone.0116838. eCollection 2015.

11. Horita A, Kurata A, Ohno S, Shimoyamada H, Saito I, Kamma H, Kuroda M.

Immaturity of mooth muscle cells in the neointima is associated with acute coronary syndrome.

Cardiovasc Pathol. 2015 Jan-Feb;24(1):26-32. doi: 10.1016/j.carpath.2014.09.003. Epub 2014 Sep 16.

 

<2014/H26>

1. Yamada M, Katano H, Yotsumoto M, Hashimoto H, Muramatsu T, Shiotsuka M, Fukutake K, Kuroda M.

 Unique expression pattern of viral proteins in human herpesvirus 8-positive plasmablastic lymphoma: a case report. 

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6415-8. eCollection 2014.

2. Tajima K, Miyake T, Koike N, Hattori T, Kumakura S, Yamaguchi T, Matsumoto T, Fujita K, Kuroda M, Ito N, Goto H. 

In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis. 

J Infect Chemother. 2014 Jun;20(6):343-9. doi: 10.1016/j.jiac.2013.10.015. Epub 2013 Dec 11.

3. Nakaya T, Ogawa S, Manabe I, Tanaka M, Sanada M, Sato T, Taketo MM, Nakao K, Clevers H, Fukayama M, Kuroda M, Nagai R. 

KLF5 regulates the integrity and oncogenicity of intestinal stem cells.  

Cancer Res. 2014 May 15;74(10):2882-91. doi: 10.1158/0008-5472.CAN-13-2574. 

4. Nakaya T, Morita K, Kurata A, Ushiku T, Igarashi T, Kuroda M, Fukayama M. 

Multifocal Kaposiform Hemangioendothelioma in Multiple Visceral Organs: An Autopsy of 9-Day-Old Female Baby. 

Human Pathology. 2014 Aug;45(8):1773-7. doi: 10.1016/j.humpath.2014.03.019. Epub 2014 Apr 18.

5. Nakaya T, Kurata A, Hashimoto H, Nishimata S, Kashiwagi Y, Fujita K, Kawashima H, Kuroda M.

Young-age-onset pancreatoduodenal carcinoma in Shwachman-Diamond syndrome. 

Pathol Int. 2014 Feb;64(2):75-80. doi: 10.1111/pin.12133.

 

<2013/H25>

1.  Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M.

Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. 

EMBO Mol Med. 2013 Nov;5(11):1720-39. doi: 10.1002/emmm.201302524. Erratum in: EMBO Mol Med. 2014 May;6(5):703.

2. Mineo S, Niikura M, Inoue S, Kuroda M, Kobayashi F.

Development of Severe Pathology in Immunized Pregnant Mice Challenged with Lethal Malaria Parasites.

Infection and Immunity. 2013 Oct;81(10):3865-3871. doi: 10.1128/IAI.00749-13.

3. Nishi H, Kuroda M, Isaka K. 

Estrogen and estrogen receptor induce matrix metalloproteinase (MMP)-26 expression in endometrial carcinomacells.  

Oncol Rep. 2013 Aug;30(2):751-6. doi: 10.3892/or.2013.2527.

4. Kurata A, Inoue S, Ohno S, Nakatsubo R, Takahashi K, Ito T, Kawasaki K, Kokubo R, Sakai T, Ubukata J, Matsubara S, Muraoka R, Yamazaki J, Hirose T, Hojo M, Watanabe E, Kuroda M. 

Correlation between number of renal cysts and aortic circumferences measured using autopsy material. 

Pathol Res Pract. 2013 Jul;209(7):441-7. doi: 10.1016/j.prp.2013.04.012.

5. Araki-sasaki K, Hirano K, Osakabe Y, Kuroda M, Kitagawa K, Mishima H, Obata H, Yamada M, Maeda N, Nishida K, Kinoshita S. 

Classification of secondary corneal amyloidosis and involvement of lactoferrin. 

Ophthalmology. 2013 Jun;120(6):1166-72. doi: 10.1016/j.ophtha.2012.11.047.

6. Araki-Sasaki K, Hirano K, Osakabe Y, Kuroda M, Kitagawa K, Mishima H, Obata H, Yamada M, Maeda N, Nishida K, Kinoshita S.  

Classification of secondary corneal amyloidosis and involvement of lactoferrin.  

Ophthalmology. 2013 Jun;120(6):1166-72. doi: 10.1016/j.ophtha.2012.11.047.

 

7. Mizutani T, Tanaka M, Tanaka R, Takanashi M, Ohno S, Kuroda M.  

Correlation analysis between microRNAs and mRNAs regulated by PPARγ in 3T3-L1 adipogenesis.

(脂肪細胞3T3-L1分化のPPARγを中心とした転写ネットワークの解析 )

東京医科大学雑誌 71(1) : 19-25, 2013.

8. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH.

Leukemia cell to endothelial cell communication via exosomal miRNAs.

Oncogene. 2013 May 30;32(22):2747-55. doi: 10.1038/onc.2012.295. (IF: 6.373)

9. Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, Kumada T, Kawada N, Kubo S, Kuroda M. The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.  

BMC Cancer (Section: Genetics, genomics and epigenetics) 2013 Mar 4;13:99. doi: 10.1186/1471-2407-13-99. (IF:3.33)​

 

10. Minegishi Y, Shibagaki Y, Mizutani A, Fujita K, Tezuka T, Kinoshita M, Kuroda M, Hattori S, Gotoh N. 

An adaptor protein complex of FRS2beta and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation. 

Cancer Science. 2013 Mar;104(3):345-52. doi: 10.1111/cas.12086.

 

11. Nakaya M, Tajima M, Kosako H, Nakaya T, Hashimoto A, Watari K, Nishihara H, Ohba M, Komiya S, Tani N, Nishida M, Taniguchi H, Sato Y, Matsumoto M, Tsuda M, Kuroda M, Inoue K, Kurose H. 

GRK6 deficiency in mice causes autoimmune disease due to impaired apoptotic cell clearance. 

Nature Communications. 2013Feb 26. 4:1532. doi: 10.1038/ncomms2540. PMCID: PMC3586722.

 

12.Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y, Kuroda M, Ochiya T. 

Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes.

SCIENTIFIC REPORTS 2013  | 3 : 1197 | DOI: 10.1038/srep01197. 1 February 2013.

 

13. Matsubayashi J, Tsuchiya K, Shimizu S, Kitagawa N, Wakabayashi Y, Kuroda M, Sakurai M, Nagao T. 

Posterior spinal artery syndrome showing marked swelling of the spinal cord: a clinico-pathological study. 

J Spinal Cord Med. 2013 Jan;36(1):31-5. doi: 10.1179/2045772312Y.0000000017.

 

 

14. Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M. 

Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells.  

Molecular Therapy. 21(1):185-191. January 2013. doi: 10.1038/mt.2012.180. (IF:6.873~7.041)

 

15. Kurata A, Saji H, Ikeda N, Kuroda M.

Case Report Intracaval and intracardiac extension of invasive thymoma complicated by superior and inferior vena cava syndrome. 

Pathology International  2013 Jan;63(1):56-62. doi: 10.1111/pin.12023.  (IF:1.722)

 

<2012/H24>

1. Borjigin N, Ohno S, Wu W, Tanaka M, Suzuki R, Fujita K, Takanashi M, Oikawa K, Goto T, Motoi T, Kosaka T, Yamamoto K, Kuroda M.

TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma.

Biochemical and Biophysical Research Communications 2012 Oct 19;427(2):355-60. doi: 10.1016/j.bbrc.2012.09.063.

2. Matsunaga Y, Kezuka T, An X, Fujita K, Matsuyama N, Matsuda R, Usui Y, Yamakawa N, Kuroda M, Goto H.

Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis. 

Invest Ophthalmol Vis Sci. 2012 Oct 9;53(11):6964-71. doi: 10.1167/iovs.12-10559.

3. Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, Matsubara K, Jau Chen Y, Yamazaki M, Funahashi S, Yoshida K, Hashimoto E, Watanabe Y, Mutoh H, Ashihara M, Kato C, Watanabe T, Yoshikubo T, Tamaoki N, Ochiya T, Kuroda M, Levine AJ, Yamazaki T.

LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. 

Stem Cells. 2012 Dec;30(12):2631-44. doi: 10.1002/stem.1257. (IF:7.781)

4. Ohno S, Ishikawa A, Kuroda M.

Roles of exosomes and microvesicles in disease pathogenesis. 

Advanced Drug Delivery Reviews. 2013 Mar;65(3):398-401. doi: 10.1016/j.addr.2012.07.019. (IF:11.502)

 

5. Hamasaki T, Suzuki H, Shirohzu H, Matsumoto T, D'Alessandro-Gabazza CN, Gil-Bernabe P, Boveda-Ruiz D, Naito M, Kobayashi T, Toda M, Mizutani T, Taguchi O, Morser J, Eguchi Y, Kuroda M, Ochiya T, Hayashi H, Gabazza EC, Ohgi T.

Efficacy of a novel class of RNA interference therapeutic agents.

PLoS One. 2012;7(8):e42655. doi: 10.1371/journal.pone.0042655.

 

6. Oikawa K, Tanaka M, Itoh S, Takanashi M, Ozaki T, Muragaki Y, Kuroda M. 

A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression. 

Br J Cancer. 2012 Jun 5;106(12):1976-9. doi: 10.1038/bjc.2012.199. (IF: 5.082)

 

7. Yamaguchi G, Takanashi M, Tanaka M, Fujita K, Ohira T, Kuroda M, Ikeda N. 

Isolation of miRNAs that target EGFR mRNA in human lung cancer. 

Biochem Biophys Res Commun. 420(2):411-6. Apr 6. 2012. doi: 10.1016/j.bbrc.2012.03.008. (IF:2.484)

 

8. Xu M, Takanashi M, Oikawa K, Nishi H, Isaka K, Yoshimoto T, Ohyashiki J, Kuroda M. 

Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen. ]

Cancer Sci. 103(4):821-7. Apr 2012. doi:10.1111/j.1349-7006.2012.02221. x. (IF:3.325)

 

9. Malon C, Brachtel E, Cosatto E, Graf HP, Kurata A, Kuroda M, Meyer JS, Saito A, Wu S, Yagi Y. 

Mitotic figure recognition: agreement among pathologists and computerized detector. Anal Cell Pathol (Amst).35(2):97-100. Feb 2012. doi:10.3233/ACP-2011-0029. (IF: 0.92)

 

 

<2011/H23>

1. Xu M, Morishima N, Mizoguchi I, Chiba Y, Fujita K, Kuroda M, Iwakura Y, Cua DJ, Yasutomo K, Mizuguchi J, Yoshimoto T. 

Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. 

Eur J Immunol. 41(10):2828-39. Oct 2011. doi: 10.1002/eji.201141291. (IF:5.103)

 

2. Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K,Aoki T, Ueda S, Takanashi M, Kuroda M. 

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. 

Cancer science. 2011 Dec;102(12):2264-71. doi: 10.1111/j.1349-7006.2011.02081.x. (IF:3.325)

 

3. Onomoto K, Morimoto S, Kawaguchi T, Toyoda H, Tanaka M, Kuroda M, Uno K, Kumada T, Matsuda F, Shimotohno K, Fujita T, Murakami Y.

Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. 

PLoS ONE. 2011;6(5):e19799. doi: 10.1371/journal.pone.0019799. (IF: 4.092)

 

4. Suzuki R, Tanaka M, Takanashi M, Hussain A, Yuan B, Toyoda H, Kuroda M. 

Anthocyanidins-enriched bilberry extracts inhibit 3T3-L1 adipocyte differentiation via the insulin pathway. 

Nutr Metab (Lond). 2011 Mar 8;8:14. doi: 10.1186/1743-7075-8-14. (IF:2.885)

 

5. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K.

The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. 

PLoS One. 2011 Jan 24;6(1):e16081. doi: 10.1371/journal.pone.0016081. (IF: 4.092)

 

6. Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M, Ohyashiki JH. 

Clinical Impact of Down-regulated Plasma miR-92a Levels in Non-Hodgkin’s Lymphoma.  

PLoS ONE. 2011 Feb 24;6(2):e16408 (IF:4.092)

 

<2010/H22>

1. Ohyashiki JH, Umezu T, Kobayashi C, Hamamura RS, Tanaka M, Kuroda M, Ohyashiki K.

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. 

BMC Res Notes. 2010 Dec 24;3:347.(IF:-)

 

2. Murakami Y, Tanaka M, Toyoda H, Hayashi K, Kuroda M, Tajima A and Shimotohno K. 

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C. 

BMC Med Genomics. 2010 Oct 22;3:48. (IF:3.693)

 

3. Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y, Aoki T, Murakami Y, Toyoda H, Kumada T, Bartenschlager R, Kato N, Ikeda M, Takashina T, Tanaka M, Suzuki R, Oikawa K, Takanashi M, Kuroda M. 

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. 

Pathol Int.60(5) 351-7 May 2010. (IF:1.624)

 

4. Zhang L, Ma J, Takeuchi M, Usui Y, Hattori T, Okunuki Y, Yamakawa N, Kezuka T, Kuroda M, Goto H.

Suppression of Experimental Autoimmune Uveoretinitis by Inducing Differention of Regulatory T Cells via Activation of Aryl Hydrocarbon Receptor. 

Investigative Ophthalmology & Visual Science. 51(4):2109-17 Apr 2010. (IF:3.597)

 

5. Iejima D, Minegishi Y, Takenaka K, Siswanto A, Watanabe M, Huang L, Watanabe T, Tanaka F, Kuroda M,Gotoh N. 

FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding. 

Oncogene. 29(21):3087-99. May 27. 2010 (IF:6.373)

 

6. Ohtomo T, Miyazawa K, Naito M, Moriya S, Kuroda M, Itoh M, Tomoda A.

Cytoprotective Effect of Imatinib Mesylate in Non-BCR-ABL-expressing Cells and Autophagosome Formation.

Biochem Biophys Res Commun. 391(1):310-5. Jan 1 2010. (IF:2.484)

 

7. Murohashi M, Hinohara K, Kuroda M, Isagawa T, Tsuji S, Kobayashi S, Umezawa K, Tojo A, Aburatani H, Gotoh N.

Gene set enrichment analysis provides insight into novel signaling pathways in breast cancer stem cells. 

British journal of cancer. 2010 Jan 5;102(1):206-12. (IF:5.042)

 

<2009/H21>

1. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T, Murakami Y, Kuroda M, Miyajima A, Kato T, Ochiya T. 

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.

Biomarkers. 14(7):529-38 Nov 2009. (IF:2.090)

 

2. Higuchi R, Nakamura F, Matsuura Y, Hattori K, Suda H, Kawazaki H, Ohta A, Kuroda M, Matsubayashi J. 

Mucinous Carcinoma of the Rectosigmoid Colon, Transforming from a Pedunculated (Ip type) Polypoid Cancer in about One Year, Report of a Case. 

Stomach and Intestine(Tokyo). 44(11):1777-84 Oct 2009. (有茎性ポリープから発育進展して大腸粘液癌の1例/早期胃癌研究会症例. 胃と腸 第44巻 第11号 別冊)

 

3. Xu M, Takanashi M, Oikawa K, Tanaka M, Nishi H, Isaka K, Kudo M, Kuroda M. 

USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. 

Biochem Biophys Res Commun.16;388(2):366-371 Oct 2009. (IF:2.484)

 

4. Takanashi M, Oikawa K, Sudo K, Tanaka M, Fujita K, Kasper R, Matsuzaki M, Kuoda M. 

Therapeutic silencing of an endogenous gene by the siRNA cream in an arthritis model mouse. 

Gene Therapy, 16(8): 982-989 Aug 2009.(IF:4.538)

 

5. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M. 

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. 

PloS ONE 4 (5): e5532., May 2009. (IF:4.092)

 

6. Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M, Kuroda M. 

HP1g epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. 

Am J Pathol, 174(1): 309-316, Jan.2009. (IF:4.890)

 

<~2008/~H20>

1. Matsubayashi J, Takanashi M, Oikawa K, Mingli Xu, Mukai K, Kuroda M, Mukai K. 

Expression of G-protein-coupled receptor kinase 4 is associated with breast cancer tumorigenesis.

 J Pathol, 216(3): 317–327, Nov 2008. (IF:7.274)

 

2. Oikawa K, Akiyoshi A, Tanaka M, Takanashi M,  Nishi H, Isaka K, Kiseki H, Idei T, Tsukahara Y, Hashimura N, Mukai K, Kuroda M. 

Expression of various types of alternatively spliced WAPL transcripts in human cervical epithelia. 

Gene, 423(1):57–62, Oct.2008. (IF:2.266)

 

3. Oikawa K, Yoshida K, Takanashi M, Tanabe H, Kiyuna T, Ogura M, Saito A, Umezawa A, Kuroda M. 

Dioxin interferes in chromosomal positioning through the aryl hydrocarbon receptor. 

Biochem Biophys Res Commun , 374(2):361–364, Sep.2008. (IF:2.484)

 

4. Zhang J, Hakansson H, Kuroda M, Yuan L. 

Wapl localization on the synaptonemal complex, a meiosis-specific proteinaceous structure that binds homologus chromosomes. 

Reprod Domest Anim. 43(1):124-6 Feb 2008 (IF:1.606)

 

5. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F, Littman DR, Taniuchi I.

Repression of interleukin (IL)-4 in T helper type 1 (Th1) cells by Runx complex through binding to IL-4 silencer. 

J Exp. Med., 204(8):1749-1755, Aug.2007 (IF:14.776)

 

6. Ohyashiki K, Tauchi T, Kuroda M, Kodama A, Ohyashiki JH.

Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2 V617F multation.

Leukemia, 21(7):1578-80, Jul 2007(IF:8.966)

 

7. Ohbayashi T, Oikawa, K, Yamada K, Nishida-Umehara C, Matsuda Y, Satoh H, Mukai H, Mukai K, Kuroda M.

Unscheduled overexpression of human WAPL promotes chromosomal instability. 

Biochem Biophys Res Commun. (IF:2.484)356(3):699-704, Mar.2007.

 

8. Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, Otsubo T, Nagao T, Izumi M, Kuroda M, Domoto H, Mukai K.

Correlation with liver metastasis of the colocalization of Arp2/3 complex and WAVE2 in colorectal carcinoma. 

Cancer Sci. 98(7):992-999,Jul.2007

 

9. Oikawa K, Ishida T, Imamura T, Yoshida K, Takanashi M, Hattori H, Ishikawa A, Fujita K, Yamamoto K, Matsubayashi J, Kuroda M, Mukai K.

Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas. 

Am J Surg Pathol , 30(3):351-6, Mar.2006.

 

10. Kuroda M, Oikawa K, Ohbayashi T, Yoshida K, Yamada K, Mimura J, Matsuda Y, Fujii-Kuriyama Y, Mukai K.

A dioxin sensitive gene, mammalian WAPL, is implicated in spermatogenesis. 

FEBS Lett, 579(1): 167-172, Jan.2005. 

 

11. Kuroda M, Kiyono T, Oikawa K, Yoshida K, Mukai K.

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target. 

Br J Cancer, 92(2): 290-293, Jan.2005.

 

12. Oshiro H, Ebihara Y, Serizawa H, Shimizu T, Teshima S, Kuroda M, Kudo M.

Idiopathic retroperitoneal fibrosis associated with immunohematological abnormalities. 

Am J Med, 118(7):782-786, Jul.2005.

 

13. Kuroda M, Oikawa K, Yoshida K, Takeuchi A, Takeuchi M, Usui M, Umezawa A, Mukai, K.

Effects of 3-Methylcholanthrene on the transcriptional activity and mRNA accumulation of the oncogene hWAPL.  

Cancer Lett, 221(1):21-28, Apr.2005.

 

14. Kuroda M, Tanabe H, Yoshida K, Oikawa K, Saito A, Kiyuna T, Mizusawa H, Mukai K.

Alteration of chromosome positioning during adipocyte differentiation. 

 J Cell Sci, 117(pt24): 5897-5903, Nov.2004.

 

15. Oikawa K, Ohbayashi T, Kiyono T, Nishi H, Isaka K, Umezawa A, Kuroda M, Mukai K.

Expression of a Novel Human Gene, Human Wings Apart-Like (hWAPL), is associated with cervical carcinogenesis and tumor progression.  

Cancer Res, 64(10): 3545-3549, May.2004.

 

16. Shinmura K, Ishida T, Goto T, Kuroda M, Hattori H, Nagai S, Imamura T, Mukai K, Imakiire A.

Expression of cyclooxygenase-2 in chondroblastoma: immunohistochemical analysis with special emphasis on local inflammatory reaction.  

Virchows Arch, 444(1): 28-35, Jan.2004.

 

17. Hattori H, Kuroda M, Ishida T, Shinmura K, Nagai S, Mukai K, Imakiire A. 

Human DNA damage checkpoints and their relevance to soft tissue sarcoma. 

Pathol Int, 54(1): 26-31, Jan.2004.

 

18. Iwaya K, Ogawa H, Kuroda M, Izumi M, Ishida T, Mukai K.

Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis. 

Clin Exp Metastasis, 20(6): 525-529, May.2003.

 

19. Nakagawa M, Akasaka Y, Kanai T, Yamashita T, Kuroda M, Takayama H, Miyazawa N.

Extragastrointestinal stromal tumor of the greater omentum: Case report and review of the literature.

Hepatogastroenterology, 50(51): 691-695, May.2003.

 

20. Oikawa K, Kosugi Y, Ohbayashi T, Kameta A, Isaka K, Takayama M, Kuroda M, Mukai K.

Increased expression of IgE-dependent histamine-releasing factor in endometriotic implants.  

J Pathol, 199(3): 318-323, Mar.2003.

 

21. Izumi M, Mochizuki M, Kuroda M, Iwaya K,  Mukai K.

Angiomyoid proliferative lesion:  an unusual stroma-rich variant of Castleman’s disease of hyaline-vascular type.  

Virchows Arch, 441: 400-405, 2002.(症例報告)

 

22. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y, Mukai K.

Expression of CD10 by stromal cells during colorectal tumor development.  

Hum Pathol, 33 (8): 806-811, Aug 2002.

23. Domoto H, Hosaka T, Oikawa K, Ohbayashi T, Ishida T, Izumi M, Iwaya K, Toguchida J, Kuroda M, Mukai K.

TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas. 

Pathol Int, 52(8): 497-500, Aug.2002.

 

24. Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai, K.

Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. 

Virchows Arch, 440(6): 589-593, Jun.2002.

25. Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K, Mukai K, Kuroda M.

Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor.  

Biochem Biophys Res Commun, 290(3): 984-987, Jan.2002.

 

26. 高橋 芳久、黒田 雅彦、泉  美貴、小杉 雅英、塚本理一郎、小林 正之、向井  清.

下肢を中心に顕著な多発性を示した類上皮血管腫の一例.

病理と臨床、Vol. 20, 1187-1191, 2002.

 

27. 岩屋 啓一、望月  衛、泉  美貴、黒田 雅彦、矢島 澄鎮、向井  清.

肝囊胞腺腫より発生したと思われる紡錘形細胞肉腫の1例.

診断病理 Vol. 18, 134-136, 2001.

28. Ohbayashi T, Oikawa K, Iwata R, Kameta A, Evine K, Isobe T, Matsuda Y, Mimura J, Fujii-Kuriyama Y, Kuroda M, Mukai K.

Dioxin induces a novel nuclear factor, DIF-3, that is implicated in spermatogenesis.  

FEBS Lett, 508(3): 341-344, Nov 2001.

 

29. Oikawa K, Ohbayashi T, Mimura J, Iwata R, Kameta A, Evine K, Iwaya K, Fujii-Kuriyama Y, Kuroda M, Mukai K 

Dioxin suppresses the checkpoint protein, MAD2, by an AhR-independent pathway.  

Cancer Res, 61(15): 5707-5709, Aug 2001.

 

30. Miyazawa K, Iwaya K, Kuroda M, Harada M, Serizawa H, Koyanagi Y, Sato Y, Mizokami Y, Matsuoka T, Mukai K.

Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: Correlation with early tumor invasion.  

Virchows Arch, 437, 508-513, 2000.

31. Kani Y, Iwaya K, Kuroda M, Harada M, Hirata F, Mukai K.

A case of cytophagic histiocytic panniculitis associated with exertional rhabdomyolysis.  

Pathol Int, 50, 858-862, 2000.

 

32. Kuroda M, Sok J, Webb L, Baechtold H, Urano F, Yin Y, Chung P, de Rooij DG, Akhmedov A, Ashley T, Ron D.

Male sterility and enhanced radiation sensitivity in TLS-/- mice.  

EMBO J, 19(3): 453-462, Feb 1, 2000.

 

33. Baechtold H, Kuroda M, Sok J, Ron D, Lopez BS, Akhmedov AT.

Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation.  

J Biol Chem, 274(48): 34337-34342, Nov 1999.

 

34. Kuroda M, Wang X, Sok J, Yin Y, Chung P, Giannotti JW, Jacobs KA, Fitz LJ, Murtha-Riel P, Turner KJ, Ron D.

Induction of a secreted protein by the myxoid liposarcoma oncogene.  

Proc Natl Acad Sci USA, 96(9): 5025-5030, Apr 1999.

 

35. Kashima T, Kawaguchi J, Takeshita S, Kuroda M, Takanashi M, Horiuchi H, Imamura T, Ishikawa Y, Ishida T, Mori S, Machinami R, Kudo A. 

Anomalous cadherin expression in osteosarcoma: Possible relationships to metastasis and morphogenesis.  

Am J Pathol, 155(5): 1549-1555, Nov 1999.

 

36. Sok J, Wang XZ, Batchvarova N, Kuroda M, Harding H, Ron D.

CHOP-Dependent stress-inducible expression of a novel form of carbonic anhydrase VI.  

Mol Cell Biol, 19(1): 495-504, Jan 1999.

37. Wang XZ, Harding HP, Zhang Y, Jolicoeur EM, Kuroda M, Ron D.

Cloning of mammalian Ire1 reveals diversity in the ER stress responses.  

EMBO J, 17(19): 5708-5717, Oct 1998.

 

38. Wang XZ, Kuroda M, Sok J, Batchvarova N, Kimmel R, Chung P, Zinszner H, Ron D.

Identification of novel stress-induced genes downstream of chop. 

 EMBO J, 17(13): 3619-3630, Jul 1998.

39. Zou YR, Kottmann AH, Kuroda M, Taniuchi I and Littmann DR:  Function of the Chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393(6685): 595-599, Jun 1998.

 

40. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D.

CHOP is implicated in programmed cell death in response to impaired function of the Endoplasmic Reticulum.  

Genes & Dev, 12(7): 982-995, Apr 1998.

 

41. Motoi T, Ishida T, Kuroda M, Horiuchi H, Oka T, Matsumoto K, Nakamura T, Machinami R

Coexpression of hepatocyte growth factor and c-Met protooncogene product in synovial sarcoma.  

Pathol Int, 48: 769-775, 1998.

 

42. Ishida T, Kuroda M, Motoi T, Oka T, Imamura T,  Machinami R.

Phenotypic diversity of neurofibromatosis 2: association with plexiform schwannoma. 

Histopathology, 32(3): 264-270, 1998.

 

43. Miura T, Miyazaki T, Kuroda M, Oka T, Machinami R, Kodama T, Shibuya M, Makuuchi M, Yazaki Y, Ohnishi S

Increased expression of vascular endothelial growth Factor in human hepatocellular carcinoma. 

J Hepatol, 27(5):  854-861, 1997.

 

44. Kashima, T, Matsushita, H, Kuroda, M, Takeuchi, H, Udagawa, H, Ishida, T, Hara, M, Machinami, R.

Biphasic synovial sarcoma of the peritoneal cavity with t(X;18) demonstrated by Reverse transcriptase polymerase chain reaction.  

Pathol Int, 47: 637-641, 1997.

 

45. Kuroda M, Ishida T, Takanashi M, Satoh M, Machinami R, Watanabe T.

Oncogenic transformation and inhibition of adipocytic conversion of preadipocyte by TLS/FUS-CHOP typeII chimeric protein. 

Am J Pathol, 151(3): 735-744, Sep 1997.

 

46. Satoh M, Nara T, Janecharut T, Furta T, Kikuchi T, Matsumoto N, Kokaze A, Kuramochi T, Kuroda M, Hattori S, Ono F, Morishita Y, Mori S, Kojima S. 

Squirrel monkeys as a useful vaccine model for Schistosoma japonicum infection. 

Parastiology Int, 46: 31-39, 1997.

 

47. Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R, Watanabe T.

Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. 

Am J Pathol, 147(5): 1221-1227, Nov 1995.

 

48. Kuroda M, Oka T, Oka Y, Yamochi T, Ohtsubo K, Mori S, Watanabe T, Machinami R, Ohnishi S.

Colocalization of vascular endothelial growth factor(Vascular permeability factor) and insulin in Pancreatic islet cells.

J Clin Endocrinol Metab, 80(11): 3196-3200, Nov 1995.

 

49. Matsushita H, Hara M, Honda K, Kuroda M, Usui M, Nakazawa H, Hara S, Shishiba Y.

Inhibition of parathyroid hormone-related protein release by extracellular calcium in dispersed cells from human parathyroid hyperplasia secondary to chronic renal failure and adenoma.

 Am J Pathol, 146(6): 1521-1528, Jul 1995.

 

50. 岡  輝明、森  正也、黒田 雅彦、宇於崎 宏、町並 陸生、四元 秀毅.

肺癌組織におけるcytokeratin 19 fragment (CYFRA21-1)の免疫組織学的検討. 

腫瘍マーカー研究会誌, 10:p75-77, 1995

 

51. Kuroda M, Oka T, Horiuchi H, Ishida T, Machinami R, Hebisawa A.

Giant cell tumor of the lung:an autopsy case report with immunohistochemical observations. 

Pathol Int, 44: 158-163, 1994.

 

52. Ishida T, Kojima T, Iijima T, Oka T, Kuroda M, Horiuchi H, Imamura T, Machinami R. 

Synovial sarcoma with a predominant epithelial component. 

Int J Surg Pathol, 1: 261-268, 1994.

 

53. Kuroda M, Horiuchi H, Oka T, Ishida T, Ono A, Kawakita M, Machinami R.

Calcium pump expression in human bone and soft tissue tumors. 

Virchows Arch A Pathol Anat Histopathol, 423(3): 209-213, Jul 1993.

 

54. Kuroda M, Horiuchi H, Ono A, Kawakita M, Oka T, Machinami R.

Immunohistochemical study on the distribution of sarcoplasmic reticulum calcium ATPase in various human tissues using novel monoclonal antibodies. 

Virchows Arch A Pathol Anat Histopathol, 421(6): 527-532, Aug 1992.

 

© 2019 Department of Molecular Pathology KURODA's Lab

This site was designed with the
.com
website builder. Create your website today.
Start Now